Geode Capital Management, LLC Cullinan Oncology, Inc. Transaction History

Geode Capital Management, LLC

  • $1.07 Trillion
  • Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 677,330 shares of CGEM stock, worth $13.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
677,330
Previous 655,664 3.3%
Holding current value
$13.7 Million
Previous $6.68 Million 72.74%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$10.17 - $19.02 $220,343 - $412,087
21,666 Added 3.3%
677,330 $11.5 Million
Q4 2023

Feb 13, 2024
BUY
$7.89 - $10.23 $511,595 - $663,323
64,841 Added 10.97%
655,664 $6.68 Million
Q3 2023

Nov 13, 2023
BUY
$9.05 - $11.72 $710,216 - $919,750
78,477 Added 15.32%
590,823 $5.35 Million
Q2 2023

Aug 11, 2023
SELL
$8.8 - $13.4 $224,197 - $341,391
-25,477 Reduced 4.74%
512,346 $5.51 Million
Q1 2023

May 15, 2023
SELL
$10.2 - $11.91 $196,707 - $229,684
-19,285 Reduced 3.46%
537,823 $5.5 Million
Q4 2022

Feb 13, 2023
BUY
$9.72 - $13.62 $151,515 - $212,308
15,588 Added 2.88%
557,108 $5.88 Million
Q3 2022

Nov 14, 2022
BUY
$11.82 - $15.42 $431,737 - $563,230
36,526 Added 7.23%
541,520 $6.94 Million
Q2 2022

Aug 12, 2022
BUY
$7.31 - $13.55 $456,531 - $846,238
62,453 Added 14.11%
504,994 $6.47 Million
Q1 2022

May 13, 2022
BUY
$10.47 - $16.75 $111,714 - $178,722
10,670 Added 2.47%
442,541 $4.63 Million
Q4 2021

Feb 11, 2022
BUY
$15.36 - $25.0 $163,322 - $265,825
10,633 Added 2.52%
431,871 $6.66 Million
Q3 2021

Nov 12, 2021
BUY
$22.56 - $29.68 $4.25 Million - $5.59 Million
188,316 Added 80.85%
421,238 $9.51 Million
Q2 2021

Aug 13, 2021
BUY
$24.96 - $41.25 $315,868 - $522,018
12,655 Added 5.75%
232,922 $6 Million
Q1 2021

May 12, 2021
BUY
$28.0 - $53.42 $6.17 Million - $11.8 Million
220,267 New
220,267 $9.18 Million

Others Institutions Holding CGEM

# of Institutions
118
Shares Held
43M
Call Options Held
12.6K
Put Options Held
4.9K
View Full List

About Cullinan Oncology, Inc.

CGEM Quotes by TradingView
  • Ticker CGEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,612,200
  • Market Cap $920M
  • Description
  • Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...
More about CGEM
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email